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REPORT
Mutations in GRHL2 Result in an Autosomal-Recessive
Ectodermal Dysplasia Syndrome
Gabriela Petrof,1 Arti Nanda,2 Jake Howden,3 Takuya Takeichi,1,4 James R. McMillan,5
Sophia Aristodemou,5 Linda Ozoemena,5 Lu Liu,5 Andrew P. South,6 Celine Pourreyron,6
Dimitra Dafou,7 Laura E. Proudfoot,1 Hejab Al-Ajmi,2 Masashi Akiyama,4 W.H. Irwin McLean,6
Michael A. Simpson,8 Maddy Parsons,3 and John A. McGrath1,6,*
Grainyhead-like 2, encoded by GRHL2, is a member of a highly conserved family of transcription factors that play essential roles during
epithelial development. Haploinsufficiency for GRHL2 has been implicated in autosomal-dominant deafness, but mutations have not
yet been associated with any skin pathology. We investigated two unrelated Kuwaiti families in which a total of six individuals have
had lifelong ectodermal defects. The clinical features comprised nail dystrophy or nail loss, marginal palmoplantar keratoderma, hypo-
dontia, enamel hypoplasia, oral hyperpigmentation, and dysphagia. In addition, three individuals had sensorineural deafness, and three
had bronchial asthma. Taken together, the features were consistent with an unusual autosomal-recessive ectodermal dysplasia syn-
drome. Because of consanguinity in both families, we used whole-exome sequencing to search for novel homozygous DNA variants
and found GRHL2mutations common to both families: affected subjects in one family were homozygous for c.1192T>C (p.Tyr398His)
in exon 9, and subjects in the other family were homozygous for c.1445T>A (p.Ile482Lys) in exon 11. Immortalized keratinocytes
(p.Ile482Lys) showed altered cell morphology, impaired tight junctions, adhesion defects, and cytoplasmic translocation of GRHL2.
Whole-skin transcriptomic analysis (p.Ile482Lys) disclosed changes in genes implicated in networks of cell-cell and cell-matrix adhesion.
Our clinical findings of an autosomal-recessive ectodermal dysplasia syndrome provide insight into the role of GRHL2 in skin develop-
ment, homeostasis, and human disease.Grainyhead-like 2 (GRHL2) is a mammalian homolog of
Drosophila protein grainy head (GRH), which, along with
GRHL1 and GRHL3, has a role in epithelial morphogen-
esis.1,2 This family of transcription factors controls the
development and differentiation of multicellular epithelia
by regulating genes germane to cell junction formation
and proliferation.3,4 Biologically, GRHL2 contributes to
formation of the epithelial barrier and wound healing,
as well as neural-tube closure, maintenance of the muco-
ciliary airway epithelium, and tumor suppression.5–11
GRHL2 (MIM 608576) has been shown to regulate TERT
(MIM 187270) expression and to enhance proliferation
of epidermal keratinocytes; it also impairs keratinocyte dif-
ferentiation through transcription inhibition of genes
clustered at the epidermal differentiation complex12 and
regulates epithelial morphogenesis by establishing func-
tional tight junctions.13
GRHL2 is also present in the cochlear duct,14 and mu-
tations in human GRHL2 have been found in progres-
sive autosomal-dominant hearing loss (DFNA28 [MIM
608641]),15,16 and other polymorphic sequence variants
in GRHL2 have been implicated in age-related hearing
impairment and noise-induced hearing loss.17–19 To date,
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fects, Grhl2 knockout is embryonically lethal in mice,17,20
and mutant zebrafish display inner-ear defects and
abnormal swimming positions.18 In contrast, Grhl1/
mice show hair loss and palmoplantar keratoderma, as
well as abnormal desmosome cell junctions and dysregu-
lated terminal differentiation in keratinocytes.21 More-
over,Grhl3/ embryos fail to establish a normal epidermal
barrier and display defective embryonic wound repair.22
Thus, unlike for GRHL1 and GRHL3, there is currently
a lack of data associating GRHL2 with skin pathology.
In this report, however, we have identified two families
in which affected subjects have developmental defects
affecting skin, oral mucosa, and teeth (as well as hearing
and lungs), thus implicatingGRHL2 in an autosomal-reces-
sive ectodermal dysplasia syndrome.
We investigated two unrelated Kuwaiti families, both
consanguineous, in which clinically similar features were
present in a total of six affected individuals (Figures 1A
and 1B). The clinical features were noted in early infancy
and comprised short stature (%25th percentile), nail
dystrophy and/or loss, oral mucosa and/or tongue pigmen-
tation, abnormal dentition (delay, hypodontia, enamel hy-
poplasia), keratoderma affecting the margins of the palmsdon SE1 9RT, UK; 2As’ad Al-HamadDermatology Center, Al-Sabah Hospital,
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Figure 1. Pedigrees and Clinical Features
of This Autosomal-Recessive Ectodermal
Dysplasia Syndrome
(A and B) Two unrelated consanguineous
pedigrees with a total of six affected indi-
viduals.
(C and D) An affected 8-year-old male
(from pedigree ED-01) and an affected 12-
year-old female (from pedigree ED-02)
both show features of tongue hyperpig-
mentation, skin thickening around the
margins of the palms and soles, hypoplas-
tic finger and toe nails, knuckle pads on
the fingers, and atrophic wrinkling on the
dorsal aspects of the hands and feet. Addi-
tional clinical images from other subjects
are shown in Figure S1.and soles, and focal hyperkeratosis of the dorsal aspects of
the hands and feet (Figures 1C and 1D; Figure S1, available
online). No individual showed any wound-healing defect,
blistering tendency, hair or sweating abnormalities, or
other developmental anomalies. Two affected sisters (ED-
02 VI-3 and VI-5) had dysphagia with evident esophageal
strictures. Three individuals (ED-01 IV-4 and IV-5 and
ED-02 VI-3) developed sensorineural deafness in early in-
fancy, and three others (ED-01 IV-4 and IV-5 and ED-02
IV-2) had bronchial asthma. One individual (ED-01 IV-4)
had severe iron-deficiency anemia requiring blood transfu-
sion. Laboratory tests (full blood count, serum biochem-
istry, immunoglobulin levels, and thyroid-function tests)
were otherwise within the normal range for all affected
individuals. None of the parents had any skin, hair, teeth,
nail, or hearing abnormalities.
To investigate the etiology of the condition, we first
assessed lesional skin biopsies taken from three affected
individuals (ED-01 IV-4 and ED-02 VI-3 and VI-5) by using
immunohistochemistry and transmission electron micro-
scopy. The subjects’ legal guardians provided written
informed consent according to a protocol approved by
the St. Thomas’ Hospital Ethics Committee (Molecular
basis of inherited skin disease: 07/H0802/104). Blood and
skin samples (ellipse of skin taken under local anesthesia
by 1% lignocaine) were obtained in adherence to the
Declaration of Helsinki guidelines. Light microscopy
showed mild acanthosis and hyperkeratosis (Figure S2),
but transmission electronmicroscopy of the skin was unre-
markable—it showed no clear abnormalities in keratino-
cytes, hemidesmosomes, or desmosome cell-cell junctions.
Likewise, skin immunolabeling using a panel of antibodiesThe American Journal of Human Genthat target basement membrane
extracellular matrix proteins (collagen
IV and collagen VII), epidermal-adhe-
sion-associated proteins (desmoglein
1, keratin 1, keratin 14, and desmopla-
kin), and markers of terminal differ-
entiation (filaggrin) showed normal
intensity and labeling patterns whenaffected skin from two affected individuals was compared
to skin from a normal control subject (Figure S3; see Sup-
plemental Data for methods and antibody details). How-
ever, we noted increased staining for the proliferation
marker Ki-67 in the epidermis (Figure S4). Collectively,
the skin-biopsy findings were not diagnostic for any
known inherited skin disease.
We then used whole-exome sequencing to identify a
candidate gene or genes. We extracted genomic DNA
from peripheral blood from two affected individuals (ED-
01 IV-4 and ED-02 VI-3). We performed whole-exome cap-
ture by using in-solution hybridization (Agilent All Exon
Kit V4) and generated sequencing on the Illumina HiSeq
2000. Resulting reads were aligned to the reference human
genome (UCSC Genome Browser hg19, GRCh37) with the
Novoalign software package (Novocraft Technologies).
Duplicate reads, resulting from PCR clonality or optical
duplicates, and reads mapping to multiple locations
were excluded from downstream analysis. A summary of
exome-coverage data is presented in Table S1. Sixteen pre-
viously unreported homozygousmutations were identified
(ten in family ED-01 and six in family ED-02). The only
gene containing homozygous variants common to both
subjects was GRHL2 (Table S2). The respective mutations
were c.1192T>C (p.Tyr398His) in exon 9 and c.1445T>A
(p.Ile482Lys) (RefSeq NM_024915.3) in exon 11. These
mutations were confirmed by Sanger sequencing (Figures
2A and 2B) and were also shown to segregate with the dis-
ease phenotype in other affected pedigree members. Both
mutations are located in the DNA binding site of GRHL2
(Figure 2C) and are predicted to be ‘‘probably damaging’’
by PolyPhen-2 analysis (scores 0.984 and 0.994 foretics 95, 308–314, September 4, 2014 309
Figure 2. Autosomal-Recessive Muta-
tions in GRHL2 Lead to Reduced Gene
Expression and Protein Levels
(A and B) Sanger sequencing confirmed
the presence of different homozygous
missense mutations in GRHL2 in affected
subjects from both pedigrees.
(C) Schematic representation of the func-
tional domains of GRHL2. The recessive
missense mutations we identified (top)
are located within the DNA binding
domain; the previously reported heterozy-
gous splice-site or deletion mutations that
cause autosomal-dominant deafness are
also illustrated (bottom).
(D) qPCR forGRHL2 expression in cultured
keratinocytes showed reduced expression
in two affected subjects from pedigree
ED-02 (*p < 0.05 in comparison to control
cells). Error bars represent the SD from
three independent experiments.
(E) Immunoblotting using cultured kerati-
nocyte whole-cell lysates revealed mark-
edly reduced or undetectable amounts of
GRHL2 in these same individuals.c.1192T>C and c.1445T>A, respectively). Neither variant
has been observed by the 1000 Genomes Project or de-
tected in ~1,200 control in-house exomes or in 260 ethni-
cally matched control chromosomes.
GRHL2 can be detected in the nuclear fraction of normal
human keratinocytes in culture (but is subsequently lost in
cell senescence).23 We cultured keratinocytes from two of
the skin biopsies (ED-02 VI-3 and ED-02 VI-5) by standard
methods and used these cells to examine GRHL2 expres-
sion and GRHL2 localization (see Supplemental Data for
methods); both were found to be reduced (Figures 2D
and 2E). We then isolated primary keratinocytes from
one of the affected individuals (ED-02 VI-5) and immortal-
ized these cells at passage 1 (see Supplemental Data for
methods). The phenotype of these cells was assessed by
confocal microscopy. GRHL2 mutant cells showed a less
cuboidal, elongated phenotype and failed to form intact
cell junctions, as seen in control immortalized keratino-
cytes. Notably, there was a reduction in cell membrane
labeling for E-cadherin (adherens junctions) and zona-
occludens-2 (tight junctions) (Figure S5). GRHL2 stain-
ing in control keratinocytes was seen both at cell-cell310 The American Journal of Human Genetics 95, 308–314, September 4, 2014contact areas and within the nu-
cleus (Figure 3A), whereas in mutant
cells, the signal was not at the pe-
riphery and instead showed a frag-
mented punctate nuclear localization
(Figure 3B). To assess the effects of
the mutations on keratinocyte cell
function, we also performed assays
of cell adhesion and de-adhesion (see
Supplemental Data for methods). No
differences were noted for cell adhe-
sion betweenmutant and control cells(Figure 3C), but mutant cells detached from fibronectin
much faster than normal human keratinocyte controls
after exposure to trypsin (Figure 3D).
Next, we assessed the transcriptome profile by using
RNA extracted from whole skin from two individuals in
pedigree ED-02. RNA from healthy control skin was ob-
tained from discarded abdominoplasty tissue from plastic
surgeons and used as four pooled samples. RNA extraction
was performed with the AmbionmirVanamiRNA Isolation
kit (Invitrogen) according to the manufacturer’s instruc-
tions. RNA was amplified with the Illumina TotalPrep
RNA Amplification Kit, and subsequent gene-expression
profiling was performed with the Illumina array Hu-
manHT-12 v4 Expression BeadChip Kit according to the
manufacturer’s instructions. Gene-expression data were
then analyzed with GenomeStudio software (Illumina). A
prefiltering set was determined for significantly modulated
expression (detection p value < 0.01; signal intensity fold
change R 2.0) between affected and control skin. A
comprehensive functional-enrichment analysis was then
performed with (1) the Database for Annotation, Visualiza-
tion, and Integrated Discovery (v.6.7), based on the Gene
Figure 3. Impact of GRHL2 Mutations on Keratinocyte Cell Biology
(A) Confocal microscopy in normal keratinocytes revealed nuclear, cytoplasmic, and membranous labeling for an antibody raised
against GRHL2.
(B) In contrast, keratinocytes from an affected subject showed an altered pattern of antibody localizationwithin the nucleus and a lack of
any cell membrane labeling.
(C) Cell-adhesion assays showed no difference between wild-type and mutant keratinocytes. Error bars represent the SD from three
independent experiments.
(D) In contrast, mutant cells showed more rapid detachment in trypsin de-adhesion assays. Error bars represent the SD from three
independent experiments. NHK stands for normal human keratinocyte.Ontology (GO) database (see Web Resources), and (2)
the GeneGo Metacore software (Thomson Reuters), a sys-
tems-biology analysis tool based on a curated database
of human protein-protein and protein-DNA interactions,
transcription factors, signaling, and metabolic pathways.
Comparison of the affected individuals’ skin with the
skin of healthy age- and site-matched control individuals
identified 1,457 gene transcripts that were significantly
altered: 668 upregulated (R2-fold change) and 789 down-
regulated (%0.5-fold change) transcripts for ED-02 VI-5.
For ED-02 VI-3, 1,141 gene transcripts were altered: 466
upregulated and 675 downregulated. Of these changes in
gene expression, 359 upregulated and 344 downregulated
gene transcripts were common to both affected subjects.
Evaluation of the changes in gene expression by func-
tional-enrichment analysis identified several enriched
GO pathways, processes, networks, and disease-associated
transcripts, some of which are germane to the known func-
tions of GRHL2. The top three upregulated GO pathways
were linked to protein-folding maturation, cytoskeleton
remodeling, and transcriptional control of lipid biosyn-
thesis (involving genes encoding proopiomelanocortinsThe Americanand mitochondrial enzymes involved in metabolic path-
ways) (Tables S3–S10). Among the most significantly
upregulated GO networks were the signal-transduction
pathways and intermediate-filament remodeling (Table
S7). Conversely, immune-response signaling; migration-
inhibitory-factor-induced cell adhesion, migration, and
angiogenesis; and networks of cell-cell and cell-matrix
adhesion were downregulated (Table S8).
With regard to skin differentiation and barrier forma-
tion, selected alterations in gene expression are presented
in Table S11. We also verified potential changes by per-
forming quantitative PCR (qPCR) with RNA from whole
skin of three individuals from the two pedigrees, as well
as immortalized keratinocytes and primary fibroblasts
from one affected person (see Supplemental Data for
methods and controls). We observed reduced expression
of GRHL2 for all templates and a contrasting increase in
GRHL1 (MIM 609786) and GRHL3 (MIM 608317) expres-
sion: unique and cooperative roles for this transcription
factor family have been previously documented.24 The
most marked skin-barrier-associated gene changes were
upregulation of aquaporin-encoding genes AQP5 (MIMJournal of Human Genetics 95, 308–314, September 4, 2014 311
600442) and AQP7 (MIM 602974), the latter of which
was expressed 503–1003 more in affected skin than in
control skin. Gain-of-function mutations in AQP5 have
previously been associated with a form of autosomal-domi-
nant nonepidermolytic palmoplantar keratoderma (MIM
600962).25 Two-fold or greater reduction in gene expres-
sion was noted for S100A8 (MIM 123885) and S100A9
(MIM 123886), known targets for GRHL1. Previously, it
has also been shown that GRHL2 enhances skin-barrier
function by upregulating the tight-junction components
claudins 3 and 4 and also Rab25, which localizes claudin
4 to tight junctions.26 In affected people, we noted in-
creases in CLDN3 (MIM 602910), CLDN4 (MIM 602909),
and RAB25 (MIM 612942) expression in whole skin (tran-
scriptome and qPCR) and cultured keratinocytes (qPCR).
Increased claudin 4 immunolabeling was also noted in
the skin of two affected individuals (Figure S5).
Labeling for the proliferationmarker Ki-67 was increased
in the affected subjects’ skin (Figure S4). This indicates that
suprabasal keratinocytes are subject to an abnormal termi-
nal-differentiation program, which provides a possible
explanation for thickening of the epidermis and impair-
ment of the epidermal barrier in our affected individuals
with mutant GRHL2, although it is unclear why the most
prominent skin scaling was found around the margins
of the soles. We also noted reduced expression of TERT
in the affected individuals’ skin and keratinocytes. Over-
expression of GRHL2 in normal keratinocytes increases
telomerase activity and increases replicative life span
(TERT and PCNA [MIM 176740]). In contrast, knockdown
of GRHL2 represses the expression of these genes.12
The impact of GRHL2 mutations on cell morphology
has been previously described.4 Lung epithelial cells trans-
duced with Grhl2 small hairpin RNA flatten in culture and
lose their cuboidal morphology into an expanded cell
phenotype. Knocking down Grhl2 in lung epithelial cell
lines leads to downregulation of Cldn4 and Cdh1.9 In our
subjects’ keratinocytes, immunostaining with E-cadherin
showed reduced expression and qPCR showed downregu-
lation of this transcript (Figure S6).
In addition to being expressed in skin, Grhl2 and GRHL2
are highly expressed in the inner ear, the lung epithelium,
the ureteric bud of the kidney, the olfactory epithelium,
the urogenital tract, the gastric mucosa, and human breast
cancer cells.4,8–11,18,27,28 With regard to the clinical pheno-
type in our affected individuals, aside from the changes
affecting the skin and oral mucosa, the other main features
comprised deafness and asthma, although this was
variably present. Three subjects (ED-01 IV-4 and IV-5
and ED-02 VI-3) had deafness that developed in early in-
fancy (c.f. the later-onset deafness in other families with
GRHL2 haploinsufficiency).15,16 Of note, none of the het-
erozygous carriers of either missense mutation in GRHL2
had any deafness. The significance of GRHL2 in vertebrate
inner-ear development is well established,16 but the lack of
deafness in the heterozygotes (and some homozygotes) in
our pedigrees indicates a different functional effect of the312 The American Journal of Human Genetics 95, 308–314, Septembmissense mutations. Deafness is not a common feature of
ectodermal dysplasia syndromes, although hearing loss
can result from abnormalities in p63 and Notch signaling
(morphological defects in organ of Corti)29 and mutations
in connexins 26 and 30 (altered endolymph ion homeosta-
sis).30 In contrast, mutagenesis studies in Grhl2 have indi-
cated a probable different pathophysiology for deafness
with enlarged otocysts, absent otoliths, and malformed
semicircular canals.16
The observation that three of the affected individuals
(ED-01 IV-4 and IV-5 and ED-02 IV-2) had clinical symp-
toms of asthma is also noteworthy because the top en-
riched GO disease among the downregulated transcripts
in our microarray data was asthma (Table S10). Previous
in situ hybridization analyses have indicated that Grhl2
is the only family member that is highly expressed in distal
lung epithelium throughout development, although the
particular cells expressing Grhl2 have not been identified,
nor has its functional role in the lung epithelium been
fully established.4 Grhl1 and Grhl3, in contrast, are ex-
pressed in the embryonic lung epithelium, but later their
expression is reduced in bronchi and bronchioles and is
undetectable in the alveolar lung epithelium.4,27 The
potential relevance of other sequence variants in GRHL2
to sporadic or familial cases of human asthma and other
obstructive-airway diseases remains to be determined.
In summary, GRHL2, a member of a family of highly
conserved transcription factors, is implicated in epithelial
morphogenesis across a number of species. We have used
whole-exome sequencing to identify GRHL2 mutations
underlying an ectodermal dysplasia syndrome in two fam-
ilies, and our data expand the current knowledge about the
role ofGRHL2 in human disease and epithelial cell biology.Supplemental Data
Supplemental Data include 6 figures and 13 tables and can be
found with this article online at http://dx.doi.org/10.1016/j.
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